Back to Browse Journals » International Journal of Nanomedicine » Volume 7

Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs

Authors Li YT, Chua MJ, Kunnath AP, Chowdhury EH

Received 2 February 2012

Accepted for publication 17 March 2012

Published 5 June 2012 Volume 2012:7 Pages 2473—2481

DOI https://dx.doi.org/10.2147/IJN.S30500

Review by Single-blind

Peer reviewer comments 4

Yong Tsuey Li,1 Ming Jang Chua,1 Anil Philip Kunnath,1 Ezharul Hoque Chowdhury,1,2

1
Faculty of Medicine and Health Science, International Medical University (IMU), No 126, Jalan 19/155B, Bukit Jalil, 57000 Kuala Lumpur, Malaysia; 2Jeffrey Cheah School of Medicine and Health Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University Kuala Lumpur, Malaysia

Background: Multidrug resistance, a major impediment to successful cancer chemotherapy, is the result of overexpression of ATP-binding cassette (ABC) transporters extruding internalized drugs. Silencing of ABC transporter gene expression with small interfering RNA (siRNA) could be an attractive approach to overcome multidrug resistance of cancer, although delivery of siRNA remains a major hurdle to fully exploit the potential of siRNA-based therapeutics. Recently, we have developed pH-sensitive carbonate apatite nanoparticles to efficiently carry and transport siRNA across the cell membrane, enabling knockdown of the cyclin B1 gene and consequential induction of apoptosis in synergy with anti-cancer drugs.
Methods and results: We report that carbonate apatite-mediated delivery of the siRNAs targeting ABCG2 and ABCB1 gene transcripts in human breast cancer cells which constitutively express both of the transporter genes dose-dependently enhanced chemosensitivity to doxorubicin, paclitaxel and cisplatin, the traditionally used chemotherapeutic agents. Moreover, codelivery of two specific siRNAs targeting ABCB1 and ABCG2 transcripts resulted in a more robust increase of chemosensitivity in the cancer cells, indicating the reversal of ABC transporter-mediated multidrug resistance.
Conclusion: The delivery concept of multiple siRNAs against ABC transporter genes is highly promising for preclinical and clinical investigation in reversing the multidrug resistance phenotype of breast cancer.

Keywords: carbonate apatite, siRNA, gene expression, transfection, breast cancer, ABC transporter, multidrug resistance, chemosensitivity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] View Full Text [HTML] 

 

Readers of this article also read:

Association between anxiety and hypertension: a systematic review and meta-analysis of epidemiological studies

Pan Y, Cai W, Cheng Q, Dong W, An T, Yan J

Neuropsychiatric Disease and Treatment 2015, 11:1121-1130

Published Date: 22 April 2015

Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors

Li W, Li H, Li J, Wang H, Zhao H, Zhang L, Xia Y, Ye Z, Gao J, Dai J, Wang H, Guo Y

International Journal of Nanomedicine 2012, 7:4661-4677

Published Date: 22 August 2012

Influences of surface coatings and components of FePt nanoparticles on the suppression of glioma cell proliferation

Sun H, Chen X, Chen D, Dong M, Fu X, Li Q, Liu X, Wu Q, Qiu T, Wan T, Li S

International Journal of Nanomedicine 2012, 7:3295-3307

Published Date: 6 July 2012

Composite scaffolds of mesoporous bioactive glass and polyamide for bone repair

Su J, Cao L, Yu B, Song S, Liu X, Wang Z, Li M

International Journal of Nanomedicine 2012, 7:2547-2555

Published Date: 21 May 2012

Comparative manufacture and cell-based delivery of antiretroviral nanoformulations

Balkundi S, Nowacek AS, Veerubhotla RS, Chen H, Martinez-Skinner A, Roy U, Mosley RL, Kanmogne G, Liu X, Kabanov AV, Bronich T, McMillan J, Gendelman HE

International Journal of Nanomedicine 2011, 6:3393-3404

Published Date: 20 December 2011

Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process

Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ

International Journal of Nanomedicine 2011, 6:2997-3009

Published Date: 24 November 2011

Reduced adhesion of macrophages on anodized titanium with select nanotube surface features

Rajyalakshmi A, Ercan B, Balasubramanian K, Webster TJ

International Journal of Nanomedicine 2011, 6:1765-1771

Published Date: 23 August 2011

Blood cleaner on-chip design for artificial human kidney manipulation

Suwanpayak N, Jalil MA, Aziz MS, Ismail FD, Ali J, Yupapin PP

International Journal of Nanomedicine 2011, 6:957-964

Published Date: 2 May 2011